Effectiveness of steroid gel in treatment of Oral Lesions

Effectiveness of Topical Betamethasone Nanogel in the treatment of Oral Lichen Planus - A Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108890

Enrollment

Registered

2026-04-21

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L439- Lichen planus, unspecified

Interventions

Intervention1: BETAMETHASONE NANOGEL: FORMULATION OF BETAMETHASONE NANOGEL FOR THE TREATMENT OF ORAL LICHEN PLANUS. FREQUENCY WILL BE TWICE APPLICATION DAILY WITH 2 REVIEWS ON 15TH AND 30TH DAY FROM

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH SYMPTOMATIC ORAL LICHEN PLANUS

Exclusion criteria

Exclusion criteria: 1. ALLERGIC TO STEROIDS 2. PATIENTS WITH COMORBIDITIES 3. PRESENCE OF LICHENOID REACTION BY FILLINGS/DRUGS 4. PREGNANT LADIES

Design outcomes

Primary

Measure	Time frame
1. SYMPTOM RELIEF 2. REDUCTION IN LESION SIZE Timepoint: 2 REVIEWS ON 15TH AND 30TH DAY FROM BASELINE.	—

Secondary

Measure	Time frame
NIL Timepoint: NIL	—

Countries

India

Contacts

Public ContactDR SHARAN KAUR MANN

SAVEETHA DENTAL COLLEGE AND HOSPITALS

SHARANMANN97@GMAIL.COM9930083443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026